Global Extreme Lateral Interbody Fusion (XLIF) Surgery Supply, Demand and Key Producers, 2023-2029
The global Extreme Lateral Interbody Fusion (XLIF) Surgery market size is expected to reach $ 1364.6 million by 2029, rising at a market growth of 4.1% CAGR during the forecast period (2023-2029).
This report studies the global Extreme Lateral Interbody Fusion (XLIF) Surgery demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Extreme Lateral Interbody Fusion (XLIF) Surgery, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Extreme Lateral Interbody Fusion (XLIF) Surgery that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Extreme Lateral Interbody Fusion (XLIF) Surgery total market, 2018-2029, (USD Million)
Global Extreme Lateral Interbody Fusion (XLIF) Surgery total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Extreme Lateral Interbody Fusion (XLIF) Surgery total market, key domestic companies and share, (USD Million)
Global Extreme Lateral Interbody Fusion (XLIF) Surgery revenue by player and market share 2018-2023, (USD Million)
Global Extreme Lateral Interbody Fusion (XLIF) Surgery total market by Type, CAGR, 2018-2029, (USD Million)
Global Extreme Lateral Interbody Fusion (XLIF) Surgery total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Extreme Lateral Interbody Fusion (XLIF) Surgery market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic Plc, Johnson & Johnson, Stryker Corporation, Zimmer Biomet Holdings Inc., NuVasive Inc., Globus Medical Inc., DePuy Synthes, B. Braun Melsungen AG and Alphatec Holdings Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Extreme Lateral Interbody Fusion (XLIF) Surgery market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market, By Region:
1. How big is the global Extreme Lateral Interbody Fusion (XLIF) Surgery market?
2. What is the demand of the global Extreme Lateral Interbody Fusion (XLIF) Surgery market?
3. What is the year over year growth of the global Extreme Lateral Interbody Fusion (XLIF) Surgery market?
4. What is the total value of the global Extreme Lateral Interbody Fusion (XLIF) Surgery market?
5. Who are the major players in the global Extreme Lateral Interbody Fusion (XLIF) Surgery market?
6. What are the growth factors driving the market demand?
This report studies the global Extreme Lateral Interbody Fusion (XLIF) Surgery demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Extreme Lateral Interbody Fusion (XLIF) Surgery, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Extreme Lateral Interbody Fusion (XLIF) Surgery that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Extreme Lateral Interbody Fusion (XLIF) Surgery total market, 2018-2029, (USD Million)
Global Extreme Lateral Interbody Fusion (XLIF) Surgery total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Extreme Lateral Interbody Fusion (XLIF) Surgery total market, key domestic companies and share, (USD Million)
Global Extreme Lateral Interbody Fusion (XLIF) Surgery revenue by player and market share 2018-2023, (USD Million)
Global Extreme Lateral Interbody Fusion (XLIF) Surgery total market by Type, CAGR, 2018-2029, (USD Million)
Global Extreme Lateral Interbody Fusion (XLIF) Surgery total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Extreme Lateral Interbody Fusion (XLIF) Surgery market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic Plc, Johnson & Johnson, Stryker Corporation, Zimmer Biomet Holdings Inc., NuVasive Inc., Globus Medical Inc., DePuy Synthes, B. Braun Melsungen AG and Alphatec Holdings Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Extreme Lateral Interbody Fusion (XLIF) Surgery market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- XLIF Interbody Fusion Systems
- XLIF Interbody Cages
- Spinal Surgery Centers
- Hospitals
- Others
- Medtronic Plc
- Johnson & Johnson
- Stryker Corporation
- Zimmer Biomet Holdings Inc.
- NuVasive Inc.
- Globus Medical Inc.
- DePuy Synthes
- B. Braun Melsungen AG
- Alphatec Holdings Inc.
- RTI Surgical Holdings Inc.
- K2M Group Holdings Inc.
- Orthofix Medical Inc.
- Aesculap Implant Systems
- SpineWave Inc.
- MicroPort Scientific Corporation
- Life Spine Inc.
- Captiva Spine Inc.
- CoreLink Surgical LLC
- CTL Medical Corporation
- Providence Medical Technology Inc.
- Safe Orthopaedics
- Spinal Elements Holdings Inc.
- Spineology Inc.
- Wenzel Spine Inc.
- Xenco Medical.
1. How big is the global Extreme Lateral Interbody Fusion (XLIF) Surgery market?
2. What is the demand of the global Extreme Lateral Interbody Fusion (XLIF) Surgery market?
3. What is the year over year growth of the global Extreme Lateral Interbody Fusion (XLIF) Surgery market?
4. What is the total value of the global Extreme Lateral Interbody Fusion (XLIF) Surgery market?
5. Who are the major players in the global Extreme Lateral Interbody Fusion (XLIF) Surgery market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
1.2 World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Extreme Lateral Interbody Fusion (XLIF) Surgery Total Market by Region (by Headquarter Location)
1.3.1 World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size (2018-2029)
1.3.3 China Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size (2018-2029)
1.3.4 Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size (2018-2029)
1.3.5 Japan Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size (2018-2029)
1.3.6 South Korea Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size (2018-2029)
1.3.7 ASEAN Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size (2018-2029)
1.3.8 India Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Extreme Lateral Interbody Fusion (XLIF) Surgery Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Extreme Lateral Interbody Fusion (XLIF) Surgery Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029)
2.2 World Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value by Region
2.2.1 World Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value by Region (2018-2023)
2.2.2 World Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value Forecast by Region (2024-2029)
2.3 United States Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029)
2.4 China Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029)
2.5 Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029)
2.6 Japan Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029)
2.7 South Korea Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029)
2.8 ASEAN Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029)
2.9 India Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029)
3 WORLD EXTREME LATERAL INTERBODY FUSION (XLIF) SURGERY COMPANIES COMPETITIVE ANALYSIS
3.1 World Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Extreme Lateral Interbody Fusion (XLIF) Surgery in 2022
3.2.3 Global Concentration Ratios (CR8) for Extreme Lateral Interbody Fusion (XLIF) Surgery in 2022
3.3 Extreme Lateral Interbody Fusion (XLIF) Surgery Company Evaluation Quadrant
3.4 Extreme Lateral Interbody Fusion (XLIF) Surgery Market: Overall Company Footprint Analysis
3.4.1 Extreme Lateral Interbody Fusion (XLIF) Surgery Market: Region Footprint
3.4.2 Extreme Lateral Interbody Fusion (XLIF) Surgery Market: Company Product Type Footprint
3.4.3 Extreme Lateral Interbody Fusion (XLIF) Surgery Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value Comparison
4.2.1 United States VS China: Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Extreme Lateral Interbody Fusion (XLIF) Surgery Companies and Market Share, 2018-2023
4.3.1 United States Based Extreme Lateral Interbody Fusion (XLIF) Surgery Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, (2018-2023)
4.4 China Based Companies Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue and Market Share, 2018-2023
4.4.1 China Based Extreme Lateral Interbody Fusion (XLIF) Surgery Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, (2018-2023)
4.5 Rest of World Based Extreme Lateral Interbody Fusion (XLIF) Surgery Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Extreme Lateral Interbody Fusion (XLIF) Surgery Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 XLIF Interbody Fusion Systems
5.2.2 XLIF Interbody Cages
5.3 Market Segment by Type
5.3.1 World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2018-2023)
5.3.2 World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2024-2029)
5.3.3 World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Spinal Surgery Centers
6.2.2 Hospitals
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2018-2023)
6.3.2 World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2024-2029)
6.3.3 World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Medtronic Plc
7.1.1 Medtronic Plc Details
7.1.2 Medtronic Plc Major Business
7.1.3 Medtronic Plc Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.1.4 Medtronic Plc Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Medtronic Plc Recent Developments/Updates
7.1.6 Medtronic Plc Competitive Strengths & Weaknesses
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Details
7.2.2 Johnson & Johnson Major Business
7.2.3 Johnson & Johnson Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.2.4 Johnson & Johnson Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Johnson & Johnson Recent Developments/Updates
7.2.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.3 Stryker Corporation
7.3.1 Stryker Corporation Details
7.3.2 Stryker Corporation Major Business
7.3.3 Stryker Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.3.4 Stryker Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Stryker Corporation Recent Developments/Updates
7.3.6 Stryker Corporation Competitive Strengths & Weaknesses
7.4 Zimmer Biomet Holdings Inc.
7.4.1 Zimmer Biomet Holdings Inc. Details
7.4.2 Zimmer Biomet Holdings Inc. Major Business
7.4.3 Zimmer Biomet Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.4.4 Zimmer Biomet Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Zimmer Biomet Holdings Inc. Recent Developments/Updates
7.4.6 Zimmer Biomet Holdings Inc. Competitive Strengths & Weaknesses
7.5 NuVasive Inc.
7.5.1 NuVasive Inc. Details
7.5.2 NuVasive Inc. Major Business
7.5.3 NuVasive Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.5.4 NuVasive Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 NuVasive Inc. Recent Developments/Updates
7.5.6 NuVasive Inc. Competitive Strengths & Weaknesses
7.6 Globus Medical Inc.
7.6.1 Globus Medical Inc. Details
7.6.2 Globus Medical Inc. Major Business
7.6.3 Globus Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.6.4 Globus Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Globus Medical Inc. Recent Developments/Updates
7.6.6 Globus Medical Inc. Competitive Strengths & Weaknesses
7.7 DePuy Synthes
7.7.1 DePuy Synthes Details
7.7.2 DePuy Synthes Major Business
7.7.3 DePuy Synthes Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.7.4 DePuy Synthes Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 DePuy Synthes Recent Developments/Updates
7.7.6 DePuy Synthes Competitive Strengths & Weaknesses
7.8 B. Braun Melsungen AG
7.8.1 B. Braun Melsungen AG Details
7.8.2 B. Braun Melsungen AG Major Business
7.8.3 B. Braun Melsungen AG Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.8.4 B. Braun Melsungen AG Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 B. Braun Melsungen AG Recent Developments/Updates
7.8.6 B. Braun Melsungen AG Competitive Strengths & Weaknesses
7.9 Alphatec Holdings Inc.
7.9.1 Alphatec Holdings Inc. Details
7.9.2 Alphatec Holdings Inc. Major Business
7.9.3 Alphatec Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.9.4 Alphatec Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Alphatec Holdings Inc. Recent Developments/Updates
7.9.6 Alphatec Holdings Inc. Competitive Strengths & Weaknesses
7.10 RTI Surgical Holdings Inc.
7.10.1 RTI Surgical Holdings Inc. Details
7.10.2 RTI Surgical Holdings Inc. Major Business
7.10.3 RTI Surgical Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.10.4 RTI Surgical Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 RTI Surgical Holdings Inc. Recent Developments/Updates
7.10.6 RTI Surgical Holdings Inc. Competitive Strengths & Weaknesses
7.11 K2M Group Holdings Inc.
7.11.1 K2M Group Holdings Inc. Details
7.11.2 K2M Group Holdings Inc. Major Business
7.11.3 K2M Group Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.11.4 K2M Group Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 K2M Group Holdings Inc. Recent Developments/Updates
7.11.6 K2M Group Holdings Inc. Competitive Strengths & Weaknesses
7.12 Orthofix Medical Inc.
7.12.1 Orthofix Medical Inc. Details
7.12.2 Orthofix Medical Inc. Major Business
7.12.3 Orthofix Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.12.4 Orthofix Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Orthofix Medical Inc. Recent Developments/Updates
7.12.6 Orthofix Medical Inc. Competitive Strengths & Weaknesses
7.13 Aesculap Implant Systems
7.13.1 Aesculap Implant Systems Details
7.13.2 Aesculap Implant Systems Major Business
7.13.3 Aesculap Implant Systems Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.13.4 Aesculap Implant Systems Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Aesculap Implant Systems Recent Developments/Updates
7.13.6 Aesculap Implant Systems Competitive Strengths & Weaknesses
7.14 SpineWave Inc.
7.14.1 SpineWave Inc. Details
7.14.2 SpineWave Inc. Major Business
7.14.3 SpineWave Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.14.4 SpineWave Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 SpineWave Inc. Recent Developments/Updates
7.14.6 SpineWave Inc. Competitive Strengths & Weaknesses
7.15 MicroPort Scientific Corporation
7.15.1 MicroPort Scientific Corporation Details
7.15.2 MicroPort Scientific Corporation Major Business
7.15.3 MicroPort Scientific Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.15.4 MicroPort Scientific Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 MicroPort Scientific Corporation Recent Developments/Updates
7.15.6 MicroPort Scientific Corporation Competitive Strengths & Weaknesses
7.16 Life Spine Inc.
7.16.1 Life Spine Inc. Details
7.16.2 Life Spine Inc. Major Business
7.16.3 Life Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.16.4 Life Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Life Spine Inc. Recent Developments/Updates
7.16.6 Life Spine Inc. Competitive Strengths & Weaknesses
7.17 Captiva Spine Inc.
7.17.1 Captiva Spine Inc. Details
7.17.2 Captiva Spine Inc. Major Business
7.17.3 Captiva Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.17.4 Captiva Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Captiva Spine Inc. Recent Developments/Updates
7.17.6 Captiva Spine Inc. Competitive Strengths & Weaknesses
7.18 CoreLink Surgical LLC
7.18.1 CoreLink Surgical LLC Details
7.18.2 CoreLink Surgical LLC Major Business
7.18.3 CoreLink Surgical LLC Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.18.4 CoreLink Surgical LLC Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 CoreLink Surgical LLC Recent Developments/Updates
7.18.6 CoreLink Surgical LLC Competitive Strengths & Weaknesses
7.19 CTL Medical Corporation
7.19.1 CTL Medical Corporation Details
7.19.2 CTL Medical Corporation Major Business
7.19.3 CTL Medical Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.19.4 CTL Medical Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 CTL Medical Corporation Recent Developments/Updates
7.19.6 CTL Medical Corporation Competitive Strengths & Weaknesses
7.20 Providence Medical Technology Inc.
7.20.1 Providence Medical Technology Inc. Details
7.20.2 Providence Medical Technology Inc. Major Business
7.20.3 Providence Medical Technology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.20.4 Providence Medical Technology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Providence Medical Technology Inc. Recent Developments/Updates
7.20.6 Providence Medical Technology Inc. Competitive Strengths & Weaknesses
7.21 Safe Orthopaedics
7.21.1 Safe Orthopaedics Details
7.21.2 Safe Orthopaedics Major Business
7.21.3 Safe Orthopaedics Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.21.4 Safe Orthopaedics Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Safe Orthopaedics Recent Developments/Updates
7.21.6 Safe Orthopaedics Competitive Strengths & Weaknesses
7.22 Spinal Elements Holdings Inc.
7.22.1 Spinal Elements Holdings Inc. Details
7.22.2 Spinal Elements Holdings Inc. Major Business
7.22.3 Spinal Elements Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.22.4 Spinal Elements Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.22.5 Spinal Elements Holdings Inc. Recent Developments/Updates
7.22.6 Spinal Elements Holdings Inc. Competitive Strengths & Weaknesses
7.23 Spineology Inc.
7.23.1 Spineology Inc. Details
7.23.2 Spineology Inc. Major Business
7.23.3 Spineology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.23.4 Spineology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.23.5 Spineology Inc. Recent Developments/Updates
7.23.6 Spineology Inc. Competitive Strengths & Weaknesses
7.24 Wenzel Spine Inc.
7.24.1 Wenzel Spine Inc. Details
7.24.2 Wenzel Spine Inc. Major Business
7.24.3 Wenzel Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.24.4 Wenzel Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.24.5 Wenzel Spine Inc. Recent Developments/Updates
7.24.6 Wenzel Spine Inc. Competitive Strengths & Weaknesses
7.25 Xenco Medical.
7.25.1 Xenco Medical. Details
7.25.2 Xenco Medical. Major Business
7.25.3 Xenco Medical. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.25.4 Xenco Medical. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.25.5 Xenco Medical. Recent Developments/Updates
7.25.6 Xenco Medical. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Extreme Lateral Interbody Fusion (XLIF) Surgery Industry Chain
8.2 Extreme Lateral Interbody Fusion (XLIF) Surgery Upstream Analysis
8.3 Extreme Lateral Interbody Fusion (XLIF) Surgery Midstream Analysis
8.4 Extreme Lateral Interbody Fusion (XLIF) Surgery Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Extreme Lateral Interbody Fusion (XLIF) Surgery Introduction
1.2 World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Extreme Lateral Interbody Fusion (XLIF) Surgery Total Market by Region (by Headquarter Location)
1.3.1 World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size (2018-2029)
1.3.3 China Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size (2018-2029)
1.3.4 Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size (2018-2029)
1.3.5 Japan Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size (2018-2029)
1.3.6 South Korea Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size (2018-2029)
1.3.7 ASEAN Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size (2018-2029)
1.3.8 India Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Extreme Lateral Interbody Fusion (XLIF) Surgery Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Extreme Lateral Interbody Fusion (XLIF) Surgery Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029)
2.2 World Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value by Region
2.2.1 World Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value by Region (2018-2023)
2.2.2 World Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value Forecast by Region (2024-2029)
2.3 United States Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029)
2.4 China Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029)
2.5 Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029)
2.6 Japan Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029)
2.7 South Korea Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029)
2.8 ASEAN Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029)
2.9 India Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029)
3 WORLD EXTREME LATERAL INTERBODY FUSION (XLIF) SURGERY COMPANIES COMPETITIVE ANALYSIS
3.1 World Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Extreme Lateral Interbody Fusion (XLIF) Surgery Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Extreme Lateral Interbody Fusion (XLIF) Surgery in 2022
3.2.3 Global Concentration Ratios (CR8) for Extreme Lateral Interbody Fusion (XLIF) Surgery in 2022
3.3 Extreme Lateral Interbody Fusion (XLIF) Surgery Company Evaluation Quadrant
3.4 Extreme Lateral Interbody Fusion (XLIF) Surgery Market: Overall Company Footprint Analysis
3.4.1 Extreme Lateral Interbody Fusion (XLIF) Surgery Market: Region Footprint
3.4.2 Extreme Lateral Interbody Fusion (XLIF) Surgery Market: Company Product Type Footprint
3.4.3 Extreme Lateral Interbody Fusion (XLIF) Surgery Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value Comparison
4.2.1 United States VS China: Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Extreme Lateral Interbody Fusion (XLIF) Surgery Companies and Market Share, 2018-2023
4.3.1 United States Based Extreme Lateral Interbody Fusion (XLIF) Surgery Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, (2018-2023)
4.4 China Based Companies Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue and Market Share, 2018-2023
4.4.1 China Based Extreme Lateral Interbody Fusion (XLIF) Surgery Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, (2018-2023)
4.5 Rest of World Based Extreme Lateral Interbody Fusion (XLIF) Surgery Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Extreme Lateral Interbody Fusion (XLIF) Surgery Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 XLIF Interbody Fusion Systems
5.2.2 XLIF Interbody Cages
5.3 Market Segment by Type
5.3.1 World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2018-2023)
5.3.2 World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2024-2029)
5.3.3 World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Spinal Surgery Centers
6.2.2 Hospitals
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2018-2023)
6.3.2 World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2024-2029)
6.3.3 World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Medtronic Plc
7.1.1 Medtronic Plc Details
7.1.2 Medtronic Plc Major Business
7.1.3 Medtronic Plc Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.1.4 Medtronic Plc Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Medtronic Plc Recent Developments/Updates
7.1.6 Medtronic Plc Competitive Strengths & Weaknesses
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Details
7.2.2 Johnson & Johnson Major Business
7.2.3 Johnson & Johnson Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.2.4 Johnson & Johnson Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Johnson & Johnson Recent Developments/Updates
7.2.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.3 Stryker Corporation
7.3.1 Stryker Corporation Details
7.3.2 Stryker Corporation Major Business
7.3.3 Stryker Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.3.4 Stryker Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Stryker Corporation Recent Developments/Updates
7.3.6 Stryker Corporation Competitive Strengths & Weaknesses
7.4 Zimmer Biomet Holdings Inc.
7.4.1 Zimmer Biomet Holdings Inc. Details
7.4.2 Zimmer Biomet Holdings Inc. Major Business
7.4.3 Zimmer Biomet Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.4.4 Zimmer Biomet Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Zimmer Biomet Holdings Inc. Recent Developments/Updates
7.4.6 Zimmer Biomet Holdings Inc. Competitive Strengths & Weaknesses
7.5 NuVasive Inc.
7.5.1 NuVasive Inc. Details
7.5.2 NuVasive Inc. Major Business
7.5.3 NuVasive Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.5.4 NuVasive Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 NuVasive Inc. Recent Developments/Updates
7.5.6 NuVasive Inc. Competitive Strengths & Weaknesses
7.6 Globus Medical Inc.
7.6.1 Globus Medical Inc. Details
7.6.2 Globus Medical Inc. Major Business
7.6.3 Globus Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.6.4 Globus Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Globus Medical Inc. Recent Developments/Updates
7.6.6 Globus Medical Inc. Competitive Strengths & Weaknesses
7.7 DePuy Synthes
7.7.1 DePuy Synthes Details
7.7.2 DePuy Synthes Major Business
7.7.3 DePuy Synthes Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.7.4 DePuy Synthes Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 DePuy Synthes Recent Developments/Updates
7.7.6 DePuy Synthes Competitive Strengths & Weaknesses
7.8 B. Braun Melsungen AG
7.8.1 B. Braun Melsungen AG Details
7.8.2 B. Braun Melsungen AG Major Business
7.8.3 B. Braun Melsungen AG Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.8.4 B. Braun Melsungen AG Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 B. Braun Melsungen AG Recent Developments/Updates
7.8.6 B. Braun Melsungen AG Competitive Strengths & Weaknesses
7.9 Alphatec Holdings Inc.
7.9.1 Alphatec Holdings Inc. Details
7.9.2 Alphatec Holdings Inc. Major Business
7.9.3 Alphatec Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.9.4 Alphatec Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Alphatec Holdings Inc. Recent Developments/Updates
7.9.6 Alphatec Holdings Inc. Competitive Strengths & Weaknesses
7.10 RTI Surgical Holdings Inc.
7.10.1 RTI Surgical Holdings Inc. Details
7.10.2 RTI Surgical Holdings Inc. Major Business
7.10.3 RTI Surgical Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.10.4 RTI Surgical Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 RTI Surgical Holdings Inc. Recent Developments/Updates
7.10.6 RTI Surgical Holdings Inc. Competitive Strengths & Weaknesses
7.11 K2M Group Holdings Inc.
7.11.1 K2M Group Holdings Inc. Details
7.11.2 K2M Group Holdings Inc. Major Business
7.11.3 K2M Group Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.11.4 K2M Group Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 K2M Group Holdings Inc. Recent Developments/Updates
7.11.6 K2M Group Holdings Inc. Competitive Strengths & Weaknesses
7.12 Orthofix Medical Inc.
7.12.1 Orthofix Medical Inc. Details
7.12.2 Orthofix Medical Inc. Major Business
7.12.3 Orthofix Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.12.4 Orthofix Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Orthofix Medical Inc. Recent Developments/Updates
7.12.6 Orthofix Medical Inc. Competitive Strengths & Weaknesses
7.13 Aesculap Implant Systems
7.13.1 Aesculap Implant Systems Details
7.13.2 Aesculap Implant Systems Major Business
7.13.3 Aesculap Implant Systems Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.13.4 Aesculap Implant Systems Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Aesculap Implant Systems Recent Developments/Updates
7.13.6 Aesculap Implant Systems Competitive Strengths & Weaknesses
7.14 SpineWave Inc.
7.14.1 SpineWave Inc. Details
7.14.2 SpineWave Inc. Major Business
7.14.3 SpineWave Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.14.4 SpineWave Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 SpineWave Inc. Recent Developments/Updates
7.14.6 SpineWave Inc. Competitive Strengths & Weaknesses
7.15 MicroPort Scientific Corporation
7.15.1 MicroPort Scientific Corporation Details
7.15.2 MicroPort Scientific Corporation Major Business
7.15.3 MicroPort Scientific Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.15.4 MicroPort Scientific Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 MicroPort Scientific Corporation Recent Developments/Updates
7.15.6 MicroPort Scientific Corporation Competitive Strengths & Weaknesses
7.16 Life Spine Inc.
7.16.1 Life Spine Inc. Details
7.16.2 Life Spine Inc. Major Business
7.16.3 Life Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.16.4 Life Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Life Spine Inc. Recent Developments/Updates
7.16.6 Life Spine Inc. Competitive Strengths & Weaknesses
7.17 Captiva Spine Inc.
7.17.1 Captiva Spine Inc. Details
7.17.2 Captiva Spine Inc. Major Business
7.17.3 Captiva Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.17.4 Captiva Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Captiva Spine Inc. Recent Developments/Updates
7.17.6 Captiva Spine Inc. Competitive Strengths & Weaknesses
7.18 CoreLink Surgical LLC
7.18.1 CoreLink Surgical LLC Details
7.18.2 CoreLink Surgical LLC Major Business
7.18.3 CoreLink Surgical LLC Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.18.4 CoreLink Surgical LLC Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 CoreLink Surgical LLC Recent Developments/Updates
7.18.6 CoreLink Surgical LLC Competitive Strengths & Weaknesses
7.19 CTL Medical Corporation
7.19.1 CTL Medical Corporation Details
7.19.2 CTL Medical Corporation Major Business
7.19.3 CTL Medical Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.19.4 CTL Medical Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 CTL Medical Corporation Recent Developments/Updates
7.19.6 CTL Medical Corporation Competitive Strengths & Weaknesses
7.20 Providence Medical Technology Inc.
7.20.1 Providence Medical Technology Inc. Details
7.20.2 Providence Medical Technology Inc. Major Business
7.20.3 Providence Medical Technology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.20.4 Providence Medical Technology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Providence Medical Technology Inc. Recent Developments/Updates
7.20.6 Providence Medical Technology Inc. Competitive Strengths & Weaknesses
7.21 Safe Orthopaedics
7.21.1 Safe Orthopaedics Details
7.21.2 Safe Orthopaedics Major Business
7.21.3 Safe Orthopaedics Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.21.4 Safe Orthopaedics Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Safe Orthopaedics Recent Developments/Updates
7.21.6 Safe Orthopaedics Competitive Strengths & Weaknesses
7.22 Spinal Elements Holdings Inc.
7.22.1 Spinal Elements Holdings Inc. Details
7.22.2 Spinal Elements Holdings Inc. Major Business
7.22.3 Spinal Elements Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.22.4 Spinal Elements Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.22.5 Spinal Elements Holdings Inc. Recent Developments/Updates
7.22.6 Spinal Elements Holdings Inc. Competitive Strengths & Weaknesses
7.23 Spineology Inc.
7.23.1 Spineology Inc. Details
7.23.2 Spineology Inc. Major Business
7.23.3 Spineology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.23.4 Spineology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.23.5 Spineology Inc. Recent Developments/Updates
7.23.6 Spineology Inc. Competitive Strengths & Weaknesses
7.24 Wenzel Spine Inc.
7.24.1 Wenzel Spine Inc. Details
7.24.2 Wenzel Spine Inc. Major Business
7.24.3 Wenzel Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.24.4 Wenzel Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.24.5 Wenzel Spine Inc. Recent Developments/Updates
7.24.6 Wenzel Spine Inc. Competitive Strengths & Weaknesses
7.25 Xenco Medical.
7.25.1 Xenco Medical. Details
7.25.2 Xenco Medical. Major Business
7.25.3 Xenco Medical. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
7.25.4 Xenco Medical. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023)
7.25.5 Xenco Medical. Recent Developments/Updates
7.25.6 Xenco Medical. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Extreme Lateral Interbody Fusion (XLIF) Surgery Industry Chain
8.2 Extreme Lateral Interbody Fusion (XLIF) Surgery Upstream Analysis
8.3 Extreme Lateral Interbody Fusion (XLIF) Surgery Midstream Analysis
8.4 Extreme Lateral Interbody Fusion (XLIF) Surgery Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Extreme Lateral Interbody Fusion (XLIF) Surgery Players in 2022
Table 12. World Extreme Lateral Interbody Fusion (XLIF) Surgery Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Company Evaluation Quadrant
Table 14. Head Office of Key Extreme Lateral Interbody Fusion (XLIF) Surgery Player
Table 15. Extreme Lateral Interbody Fusion (XLIF) Surgery Market: Company Product Type Footprint
Table 16. Extreme Lateral Interbody Fusion (XLIF) Surgery Market: Company Product Application Footprint
Table 17. Extreme Lateral Interbody Fusion (XLIF) Surgery Mergers & Acquisitions Activity
Table 18. United States VS China Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Extreme Lateral Interbody Fusion (XLIF) Surgery Companies, Headquarters (States, Country)
Table 21. United States Based Companies Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share (2018-2023)
Table 23. China Based Extreme Lateral Interbody Fusion (XLIF) Surgery Companies, Headquarters (Province, Country)
Table 24. China Based Companies Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share (2018-2023)
Table 26. Rest of World Based Extreme Lateral Interbody Fusion (XLIF) Surgery Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share (2018-2023)
Table 29. World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2018-2023) & (USD Million)
Table 31. World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2024-2029) & (USD Million)
Table 32. World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2018-2023) & (USD Million)
Table 34. World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2024-2029) & (USD Million)
Table 35. Medtronic Plc Basic Information, Area Served and Competitors
Table 36. Medtronic Plc Major Business
Table 37. Medtronic Plc Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 38. Medtronic Plc Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Medtronic Plc Recent Developments/Updates
Table 40. Medtronic Plc Competitive Strengths & Weaknesses
Table 41. Johnson & Johnson Basic Information, Area Served and Competitors
Table 42. Johnson & Johnson Major Business
Table 43. Johnson & Johnson Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 44. Johnson & Johnson Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Johnson & Johnson Recent Developments/Updates
Table 46. Johnson & Johnson Competitive Strengths & Weaknesses
Table 47. Stryker Corporation Basic Information, Area Served and Competitors
Table 48. Stryker Corporation Major Business
Table 49. Stryker Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 50. Stryker Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Stryker Corporation Recent Developments/Updates
Table 52. Stryker Corporation Competitive Strengths & Weaknesses
Table 53. Zimmer Biomet Holdings Inc. Basic Information, Area Served and Competitors
Table 54. Zimmer Biomet Holdings Inc. Major Business
Table 55. Zimmer Biomet Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 56. Zimmer Biomet Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Zimmer Biomet Holdings Inc. Recent Developments/Updates
Table 58. Zimmer Biomet Holdings Inc. Competitive Strengths & Weaknesses
Table 59. NuVasive Inc. Basic Information, Area Served and Competitors
Table 60. NuVasive Inc. Major Business
Table 61. NuVasive Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 62. NuVasive Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. NuVasive Inc. Recent Developments/Updates
Table 64. NuVasive Inc. Competitive Strengths & Weaknesses
Table 65. Globus Medical Inc. Basic Information, Area Served and Competitors
Table 66. Globus Medical Inc. Major Business
Table 67. Globus Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 68. Globus Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Globus Medical Inc. Recent Developments/Updates
Table 70. Globus Medical Inc. Competitive Strengths & Weaknesses
Table 71. DePuy Synthes Basic Information, Area Served and Competitors
Table 72. DePuy Synthes Major Business
Table 73. DePuy Synthes Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 74. DePuy Synthes Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. DePuy Synthes Recent Developments/Updates
Table 76. DePuy Synthes Competitive Strengths & Weaknesses
Table 77. B. Braun Melsungen AG Basic Information, Area Served and Competitors
Table 78. B. Braun Melsungen AG Major Business
Table 79. B. Braun Melsungen AG Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 80. B. Braun Melsungen AG Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. B. Braun Melsungen AG Recent Developments/Updates
Table 82. B. Braun Melsungen AG Competitive Strengths & Weaknesses
Table 83. Alphatec Holdings Inc. Basic Information, Area Served and Competitors
Table 84. Alphatec Holdings Inc. Major Business
Table 85. Alphatec Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 86. Alphatec Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Alphatec Holdings Inc. Recent Developments/Updates
Table 88. Alphatec Holdings Inc. Competitive Strengths & Weaknesses
Table 89. RTI Surgical Holdings Inc. Basic Information, Area Served and Competitors
Table 90. RTI Surgical Holdings Inc. Major Business
Table 91. RTI Surgical Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 92. RTI Surgical Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. RTI Surgical Holdings Inc. Recent Developments/Updates
Table 94. RTI Surgical Holdings Inc. Competitive Strengths & Weaknesses
Table 95. K2M Group Holdings Inc. Basic Information, Area Served and Competitors
Table 96. K2M Group Holdings Inc. Major Business
Table 97. K2M Group Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 98. K2M Group Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. K2M Group Holdings Inc. Recent Developments/Updates
Table 100. K2M Group Holdings Inc. Competitive Strengths & Weaknesses
Table 101. Orthofix Medical Inc. Basic Information, Area Served and Competitors
Table 102. Orthofix Medical Inc. Major Business
Table 103. Orthofix Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 104. Orthofix Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Orthofix Medical Inc. Recent Developments/Updates
Table 106. Orthofix Medical Inc. Competitive Strengths & Weaknesses
Table 107. Aesculap Implant Systems Basic Information, Area Served and Competitors
Table 108. Aesculap Implant Systems Major Business
Table 109. Aesculap Implant Systems Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 110. Aesculap Implant Systems Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Aesculap Implant Systems Recent Developments/Updates
Table 112. Aesculap Implant Systems Competitive Strengths & Weaknesses
Table 113. SpineWave Inc. Basic Information, Area Served and Competitors
Table 114. SpineWave Inc. Major Business
Table 115. SpineWave Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 116. SpineWave Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. SpineWave Inc. Recent Developments/Updates
Table 118. SpineWave Inc. Competitive Strengths & Weaknesses
Table 119. MicroPort Scientific Corporation Basic Information, Area Served and Competitors
Table 120. MicroPort Scientific Corporation Major Business
Table 121. MicroPort Scientific Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 122. MicroPort Scientific Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. MicroPort Scientific Corporation Recent Developments/Updates
Table 124. MicroPort Scientific Corporation Competitive Strengths & Weaknesses
Table 125. Life Spine Inc. Basic Information, Area Served and Competitors
Table 126. Life Spine Inc. Major Business
Table 127. Life Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 128. Life Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Life Spine Inc. Recent Developments/Updates
Table 130. Life Spine Inc. Competitive Strengths & Weaknesses
Table 131. Captiva Spine Inc. Basic Information, Area Served and Competitors
Table 132. Captiva Spine Inc. Major Business
Table 133. Captiva Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 134. Captiva Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Captiva Spine Inc. Recent Developments/Updates
Table 136. Captiva Spine Inc. Competitive Strengths & Weaknesses
Table 137. CoreLink Surgical LLC Basic Information, Area Served and Competitors
Table 138. CoreLink Surgical LLC Major Business
Table 139. CoreLink Surgical LLC Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 140. CoreLink Surgical LLC Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. CoreLink Surgical LLC Recent Developments/Updates
Table 142. CoreLink Surgical LLC Competitive Strengths & Weaknesses
Table 143. CTL Medical Corporation Basic Information, Area Served and Competitors
Table 144. CTL Medical Corporation Major Business
Table 145. CTL Medical Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 146. CTL Medical Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. CTL Medical Corporation Recent Developments/Updates
Table 148. CTL Medical Corporation Competitive Strengths & Weaknesses
Table 149. Providence Medical Technology Inc. Basic Information, Area Served and Competitors
Table 150. Providence Medical Technology Inc. Major Business
Table 151. Providence Medical Technology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 152. Providence Medical Technology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. Providence Medical Technology Inc. Recent Developments/Updates
Table 154. Providence Medical Technology Inc. Competitive Strengths & Weaknesses
Table 155. Safe Orthopaedics Basic Information, Area Served and Competitors
Table 156. Safe Orthopaedics Major Business
Table 157. Safe Orthopaedics Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 158. Safe Orthopaedics Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. Safe Orthopaedics Recent Developments/Updates
Table 160. Safe Orthopaedics Competitive Strengths & Weaknesses
Table 161. Spinal Elements Holdings Inc. Basic Information, Area Served and Competitors
Table 162. Spinal Elements Holdings Inc. Major Business
Table 163. Spinal Elements Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 164. Spinal Elements Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 165. Spinal Elements Holdings Inc. Recent Developments/Updates
Table 166. Spinal Elements Holdings Inc. Competitive Strengths & Weaknesses
Table 167. Spineology Inc. Basic Information, Area Served and Competitors
Table 168. Spineology Inc. Major Business
Table 169. Spineology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 170. Spineology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 171. Spineology Inc. Recent Developments/Updates
Table 172. Spineology Inc. Competitive Strengths & Weaknesses
Table 173. Wenzel Spine Inc. Basic Information, Area Served and Competitors
Table 174. Wenzel Spine Inc. Major Business
Table 175. Wenzel Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 176. Wenzel Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 177. Wenzel Spine Inc. Recent Developments/Updates
Table 178. Xenco Medical. Basic Information, Area Served and Competitors
Table 179. Xenco Medical. Major Business
Table 180. Xenco Medical. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 181. Xenco Medical. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 182. Global Key Players of Extreme Lateral Interbody Fusion (XLIF) Surgery Upstream (Raw Materials)
Table 183. Extreme Lateral Interbody Fusion (XLIF) Surgery Typical Customers
Table 1. World Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Extreme Lateral Interbody Fusion (XLIF) Surgery Players in 2022
Table 12. World Extreme Lateral Interbody Fusion (XLIF) Surgery Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Extreme Lateral Interbody Fusion (XLIF) Surgery Company Evaluation Quadrant
Table 14. Head Office of Key Extreme Lateral Interbody Fusion (XLIF) Surgery Player
Table 15. Extreme Lateral Interbody Fusion (XLIF) Surgery Market: Company Product Type Footprint
Table 16. Extreme Lateral Interbody Fusion (XLIF) Surgery Market: Company Product Application Footprint
Table 17. Extreme Lateral Interbody Fusion (XLIF) Surgery Mergers & Acquisitions Activity
Table 18. United States VS China Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Extreme Lateral Interbody Fusion (XLIF) Surgery Companies, Headquarters (States, Country)
Table 21. United States Based Companies Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share (2018-2023)
Table 23. China Based Extreme Lateral Interbody Fusion (XLIF) Surgery Companies, Headquarters (Province, Country)
Table 24. China Based Companies Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share (2018-2023)
Table 26. Rest of World Based Extreme Lateral Interbody Fusion (XLIF) Surgery Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share (2018-2023)
Table 29. World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2018-2023) & (USD Million)
Table 31. World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type (2024-2029) & (USD Million)
Table 32. World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2018-2023) & (USD Million)
Table 34. World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application (2024-2029) & (USD Million)
Table 35. Medtronic Plc Basic Information, Area Served and Competitors
Table 36. Medtronic Plc Major Business
Table 37. Medtronic Plc Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 38. Medtronic Plc Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Medtronic Plc Recent Developments/Updates
Table 40. Medtronic Plc Competitive Strengths & Weaknesses
Table 41. Johnson & Johnson Basic Information, Area Served and Competitors
Table 42. Johnson & Johnson Major Business
Table 43. Johnson & Johnson Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 44. Johnson & Johnson Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Johnson & Johnson Recent Developments/Updates
Table 46. Johnson & Johnson Competitive Strengths & Weaknesses
Table 47. Stryker Corporation Basic Information, Area Served and Competitors
Table 48. Stryker Corporation Major Business
Table 49. Stryker Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 50. Stryker Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Stryker Corporation Recent Developments/Updates
Table 52. Stryker Corporation Competitive Strengths & Weaknesses
Table 53. Zimmer Biomet Holdings Inc. Basic Information, Area Served and Competitors
Table 54. Zimmer Biomet Holdings Inc. Major Business
Table 55. Zimmer Biomet Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 56. Zimmer Biomet Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Zimmer Biomet Holdings Inc. Recent Developments/Updates
Table 58. Zimmer Biomet Holdings Inc. Competitive Strengths & Weaknesses
Table 59. NuVasive Inc. Basic Information, Area Served and Competitors
Table 60. NuVasive Inc. Major Business
Table 61. NuVasive Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 62. NuVasive Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. NuVasive Inc. Recent Developments/Updates
Table 64. NuVasive Inc. Competitive Strengths & Weaknesses
Table 65. Globus Medical Inc. Basic Information, Area Served and Competitors
Table 66. Globus Medical Inc. Major Business
Table 67. Globus Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 68. Globus Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Globus Medical Inc. Recent Developments/Updates
Table 70. Globus Medical Inc. Competitive Strengths & Weaknesses
Table 71. DePuy Synthes Basic Information, Area Served and Competitors
Table 72. DePuy Synthes Major Business
Table 73. DePuy Synthes Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 74. DePuy Synthes Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. DePuy Synthes Recent Developments/Updates
Table 76. DePuy Synthes Competitive Strengths & Weaknesses
Table 77. B. Braun Melsungen AG Basic Information, Area Served and Competitors
Table 78. B. Braun Melsungen AG Major Business
Table 79. B. Braun Melsungen AG Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 80. B. Braun Melsungen AG Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. B. Braun Melsungen AG Recent Developments/Updates
Table 82. B. Braun Melsungen AG Competitive Strengths & Weaknesses
Table 83. Alphatec Holdings Inc. Basic Information, Area Served and Competitors
Table 84. Alphatec Holdings Inc. Major Business
Table 85. Alphatec Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 86. Alphatec Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Alphatec Holdings Inc. Recent Developments/Updates
Table 88. Alphatec Holdings Inc. Competitive Strengths & Weaknesses
Table 89. RTI Surgical Holdings Inc. Basic Information, Area Served and Competitors
Table 90. RTI Surgical Holdings Inc. Major Business
Table 91. RTI Surgical Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 92. RTI Surgical Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. RTI Surgical Holdings Inc. Recent Developments/Updates
Table 94. RTI Surgical Holdings Inc. Competitive Strengths & Weaknesses
Table 95. K2M Group Holdings Inc. Basic Information, Area Served and Competitors
Table 96. K2M Group Holdings Inc. Major Business
Table 97. K2M Group Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 98. K2M Group Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. K2M Group Holdings Inc. Recent Developments/Updates
Table 100. K2M Group Holdings Inc. Competitive Strengths & Weaknesses
Table 101. Orthofix Medical Inc. Basic Information, Area Served and Competitors
Table 102. Orthofix Medical Inc. Major Business
Table 103. Orthofix Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 104. Orthofix Medical Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Orthofix Medical Inc. Recent Developments/Updates
Table 106. Orthofix Medical Inc. Competitive Strengths & Weaknesses
Table 107. Aesculap Implant Systems Basic Information, Area Served and Competitors
Table 108. Aesculap Implant Systems Major Business
Table 109. Aesculap Implant Systems Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 110. Aesculap Implant Systems Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Aesculap Implant Systems Recent Developments/Updates
Table 112. Aesculap Implant Systems Competitive Strengths & Weaknesses
Table 113. SpineWave Inc. Basic Information, Area Served and Competitors
Table 114. SpineWave Inc. Major Business
Table 115. SpineWave Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 116. SpineWave Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. SpineWave Inc. Recent Developments/Updates
Table 118. SpineWave Inc. Competitive Strengths & Weaknesses
Table 119. MicroPort Scientific Corporation Basic Information, Area Served and Competitors
Table 120. MicroPort Scientific Corporation Major Business
Table 121. MicroPort Scientific Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 122. MicroPort Scientific Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. MicroPort Scientific Corporation Recent Developments/Updates
Table 124. MicroPort Scientific Corporation Competitive Strengths & Weaknesses
Table 125. Life Spine Inc. Basic Information, Area Served and Competitors
Table 126. Life Spine Inc. Major Business
Table 127. Life Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 128. Life Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Life Spine Inc. Recent Developments/Updates
Table 130. Life Spine Inc. Competitive Strengths & Weaknesses
Table 131. Captiva Spine Inc. Basic Information, Area Served and Competitors
Table 132. Captiva Spine Inc. Major Business
Table 133. Captiva Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 134. Captiva Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Captiva Spine Inc. Recent Developments/Updates
Table 136. Captiva Spine Inc. Competitive Strengths & Weaknesses
Table 137. CoreLink Surgical LLC Basic Information, Area Served and Competitors
Table 138. CoreLink Surgical LLC Major Business
Table 139. CoreLink Surgical LLC Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 140. CoreLink Surgical LLC Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. CoreLink Surgical LLC Recent Developments/Updates
Table 142. CoreLink Surgical LLC Competitive Strengths & Weaknesses
Table 143. CTL Medical Corporation Basic Information, Area Served and Competitors
Table 144. CTL Medical Corporation Major Business
Table 145. CTL Medical Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 146. CTL Medical Corporation Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. CTL Medical Corporation Recent Developments/Updates
Table 148. CTL Medical Corporation Competitive Strengths & Weaknesses
Table 149. Providence Medical Technology Inc. Basic Information, Area Served and Competitors
Table 150. Providence Medical Technology Inc. Major Business
Table 151. Providence Medical Technology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 152. Providence Medical Technology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. Providence Medical Technology Inc. Recent Developments/Updates
Table 154. Providence Medical Technology Inc. Competitive Strengths & Weaknesses
Table 155. Safe Orthopaedics Basic Information, Area Served and Competitors
Table 156. Safe Orthopaedics Major Business
Table 157. Safe Orthopaedics Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 158. Safe Orthopaedics Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. Safe Orthopaedics Recent Developments/Updates
Table 160. Safe Orthopaedics Competitive Strengths & Weaknesses
Table 161. Spinal Elements Holdings Inc. Basic Information, Area Served and Competitors
Table 162. Spinal Elements Holdings Inc. Major Business
Table 163. Spinal Elements Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 164. Spinal Elements Holdings Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 165. Spinal Elements Holdings Inc. Recent Developments/Updates
Table 166. Spinal Elements Holdings Inc. Competitive Strengths & Weaknesses
Table 167. Spineology Inc. Basic Information, Area Served and Competitors
Table 168. Spineology Inc. Major Business
Table 169. Spineology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 170. Spineology Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 171. Spineology Inc. Recent Developments/Updates
Table 172. Spineology Inc. Competitive Strengths & Weaknesses
Table 173. Wenzel Spine Inc. Basic Information, Area Served and Competitors
Table 174. Wenzel Spine Inc. Major Business
Table 175. Wenzel Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 176. Wenzel Spine Inc. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 177. Wenzel Spine Inc. Recent Developments/Updates
Table 178. Xenco Medical. Basic Information, Area Served and Competitors
Table 179. Xenco Medical. Major Business
Table 180. Xenco Medical. Extreme Lateral Interbody Fusion (XLIF) Surgery Product and Services
Table 181. Xenco Medical. Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 182. Global Key Players of Extreme Lateral Interbody Fusion (XLIF) Surgery Upstream (Raw Materials)
Table 183. Extreme Lateral Interbody Fusion (XLIF) Surgery Typical Customers
LIST OF FIGURES
Figure 1. Extreme Lateral Interbody Fusion (XLIF) Surgery Picture
Figure 2. World Extreme Lateral Interbody Fusion (XLIF) Surgery Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Extreme Lateral Interbody Fusion (XLIF) Surgery Total Market Size (2018-2029) & (USD Million)
Figure 4. World Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue (2018-2029) & (USD Million)
Figure 13. Extreme Lateral Interbody Fusion (XLIF) Surgery Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029) & (USD Million)
Figure 16. World Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029) & (USD Million)
Figure 18. China Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029) & (USD Million)
Figure 23. India Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Extreme Lateral Interbody Fusion (XLIF) Surgery by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Extreme Lateral Interbody Fusion (XLIF) Surgery Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Extreme Lateral Interbody Fusion (XLIF) Surgery Markets in 2022
Figure 27. United States VS China: Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Market Share by Type in 2022
Figure 31. XLIF Interbody Fusion Systems
Figure 32. XLIF Interbody Cages
Figure 33. World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Market Share by Type (2018-2029)
Figure 34. World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Market Share by Application in 2022
Figure 36. Spinal Surgery Centers
Figure 37. Hospitals
Figure 38. Others
Figure 39. Extreme Lateral Interbody Fusion (XLIF) Surgery Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Figure 1. Extreme Lateral Interbody Fusion (XLIF) Surgery Picture
Figure 2. World Extreme Lateral Interbody Fusion (XLIF) Surgery Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Extreme Lateral Interbody Fusion (XLIF) Surgery Total Market Size (2018-2029) & (USD Million)
Figure 4. World Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue (2018-2029) & (USD Million)
Figure 13. Extreme Lateral Interbody Fusion (XLIF) Surgery Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029) & (USD Million)
Figure 16. World Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029) & (USD Million)
Figure 18. China Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029) & (USD Million)
Figure 23. India Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Extreme Lateral Interbody Fusion (XLIF) Surgery by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Extreme Lateral Interbody Fusion (XLIF) Surgery Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Extreme Lateral Interbody Fusion (XLIF) Surgery Markets in 2022
Figure 27. United States VS China: Extreme Lateral Interbody Fusion (XLIF) Surgery Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Extreme Lateral Interbody Fusion (XLIF) Surgery Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Market Share by Type in 2022
Figure 31. XLIF Interbody Fusion Systems
Figure 32. XLIF Interbody Cages
Figure 33. World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Market Share by Type (2018-2029)
Figure 34. World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Market Share by Application in 2022
Figure 36. Spinal Surgery Centers
Figure 37. Hospitals
Figure 38. Others
Figure 39. Extreme Lateral Interbody Fusion (XLIF) Surgery Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
